News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Frost & Sullivan Release: High Unmet Need Spurs European Lung Cancer Therapeutics Market


7/21/2008 12:52:38 PM

LONDON--(BUSINESS WIRE)--Revenues in the European lung cancer therapeutics market are set to grow at an accelerated pace due to the anticipated launch of products currently in phase III of development and the recent introduction of targeted therapies. Pharmaceutical and biotech companies are investing significant amounts of money in R&D in this sector.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES